{
     "PMID": "7641312",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19950919",
     "LR": "20161123",
     "IS": "0009-2363 (Print) 0009-2363 (Linking)",
     "VI": "43",
     "IP": "6",
     "DP": "1995 Jun",
     "TI": "Alpha 1-adrenoceptor reagents. Synthesis of some 5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido and 5,6,11,11b-tetrahydro-1H-imidazo[1',5':1,2]pyrido[3,4-b]indole-1,3(2H) -diones.",
     "PG": "941-6",
     "AB": "Several 2-substituted 5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido (1) and 5,6,11,11b-tetrahydro-1H-imidazo [1',5':1,2]pyrido[3,4-b]indole,3(2H)-diones (2) were synthesized and studied by 2D-NMR spectroscopy and difference nuclear Overhauser effect experiments. All the compounds were evaluated for in vitro alpha(1) adrenoceptor affinity by radioligand receptor binding assays. The most active derivative in displacement of [3H]prazosin from rat cortical membranes was 1b (K(i) = 219 nM). At 1 microM concentration, compounds 1 and 2 had no effect on the benzodiazepine or 5-HT(1A) receptor. The biological activity profile of 1b makes it a possible lead compound for the design of new selective alpha1 adrenoceptor ligands.",
     "FAU": [
          "Lopez-Rodriguez, M L",
          "Morcillo, M J",
          "Benhamu, B",
          "Fernandez, E",
          "Serrano, J",
          "Orensanz, L"
     ],
     "AU": [
          "Lopez-Rodriguez ML",
          "Morcillo MJ",
          "Benhamu B",
          "Fernandez E",
          "Serrano J",
          "Orensanz L"
     ],
     "AD": "Departamento de Quimica Organica I, Facultad de Ciencias Quimicas, Universidad Complutense, Madrid, Spain.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Japan",
     "TA": "Chem Pharm Bull (Tokyo)",
     "JT": "Chemical & pharmaceutical bulletin",
     "JID": "0377775",
     "RN": [
          "0 (Imidazoles)",
          "0 (Indoles)",
          "0 (Pyridines)",
          "0 (Receptors, Adrenergic, alpha-1)",
          "0 (Receptors, Serotonin)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Chemical Phenomena",
          "Chemistry, Physical",
          "Hippocampus/drug effects/metabolism",
          "Imidazoles/*chemical synthesis/pharmacology",
          "In Vitro Techniques",
          "Indoles/*chemical synthesis/pharmacology",
          "Magnetic Resonance Spectroscopy",
          "Male",
          "Molecular Conformation",
          "Oxidation-Reduction",
          "Pyridines/*chemical synthesis/pharmacology",
          "Rats",
          "Rats, Sprague-Dawley",
          "Receptors, Adrenergic, alpha-1/*drug effects",
          "Receptors, Serotonin/drug effects/metabolism"
     ],
     "EDAT": "1995/06/01 00:00",
     "MHDA": "1995/06/01 00:01",
     "CRDT": [
          "1995/06/01 00:00"
     ],
     "PHST": [
          "1995/06/01 00:00 [pubmed]",
          "1995/06/01 00:01 [medline]",
          "1995/06/01 00:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "Chem Pharm Bull (Tokyo). 1995 Jun;43(6):941-6.",
     "term": "hippocampus"
}